Literature DB >> 20933286

Depressive symptoms in stroke patients: a 13 month follow-up study of patients referred to a rehabilitation unit.

Lasse Farner1, Jørgen Wagle, Knut Engedal, Kjell M Flekkøy, Torgeir Bruun Wyller, Brynjar Fure.   

Abstract

BACKGROUND: Although depression is known to be frequently associated with stroke, it is nonetheless underdiagnosed and under-treated in this patient population. Its effect on outcome for stroke patients is thought to be substantial, but prediction is complicated by other pre- and post stroke factors. The aims of this study was to describe changes in depressive symptoms in elderly stroke patients across a timespan of one year, to examine risk factor for such changes and to explore whether depressive symptoms have any independent impact upon one year mortality and nursing home placement.
METHODS: 194 patients diagnosed with an ischaemic or hemorrhagic stroke was recruited from the Stroke Rehabilitation Unit, Ullevaal University Hospital, Oslo, Norway during the period between March 2005 and August 2006 and followed up for a period of 13 months. Pre-stroke assessment was accomplished by means of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), the Frenchay Activities Index (FAI), the Barthel ADL Index and patient's medical history. Post-stroke assessment at inclusion and follow-up examination was performed with the Mini Mental State Examination (MMSE), the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the Star Cancellation Test, the Barthel ADL Index, the modified Rankin Scale (mRS) and the National Institute of Health Stroke Scale (NIHSS). Information was collected from the patients' records.
RESULTS: Institutionalization at 13 months was predicted by more depression (MADRS) and cognitive impairment (RBANS) at baseline, together with lower pre-stroke social activity levels (FAI). Two factors predicted death at 13 months: Cognitive impairment (MMSE) and greater age. The prevalence of depression was relatively unchanged from baseline (56%) to 13 month follow-up (48%). Among the patients who were depressed at baseline 55% still had MADRS score above six (persistent depression) at 13 months, while 35% in the non-depressed group at baseline had developed depression (incident depression). Persistent depression was significantly predicted by lower pre-stroke social activity levels (FAI) together with a more severe stroke (NIHSS) and worse overall function (mRS) at baseline. Incident depression was predicted by receipt of municipal home help before the stroke and a lower score on the delayed memory tasks on RBANS at baseline.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20933286     DOI: 10.1016/j.jad.2010.05.025

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  26 in total

1.  Serum levels of homocysteine at admission are associated with post-stroke depression in acute ischemic stroke.

Authors:  Yan Li; Li-Li Cao; Lin Liu; Qin-De Qi
Journal:  Neurol Sci       Date:  2017-02-18       Impact factor: 3.307

2.  Burden of Depressive Symptoms Over 2 Decades and Risk of Nursing Home Placement in Older Women.

Authors:  Amy L Byers; Li-Yung Lui; Eric Vittinghoff; Kenneth E Covinsky; Kristine E Ensrud; Brent Taylor; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2018-08-09       Impact factor: 5.562

3.  Serum Levels of High-sensitivity C-Reactive Protein at Admission Are More Strongly Associated with Poststroke Depression in Acute Ischemic Stroke than Homocysteine Levels.

Authors:  Chao-Zhi Tang; Yu-Ling Zhang; Wen-Sheng Wang; Wei-Guo Li; Ji-Peng Shi
Journal:  Mol Neurobiol       Date:  2015-05-05       Impact factor: 5.590

4.  Late-Life Depressive and Anxiety Symptoms Following Rehabilitation Services in Medicare Beneficiaries.

Authors:  Adam Simning; Julie Kittel; Yeates Conwell
Journal:  Am J Geriatr Psychiatry       Date:  2018-12-13       Impact factor: 4.105

5.  Improving Quality of Life and Depression After Stroke Through Telerehabilitation.

Authors:  Susan M Linder; Anson B Rosenfeldt; R Curtis Bay; Komal Sahu; Steven L Wolf; Jay L Alberts
Journal:  Am J Occup Ther       Date:  2015 Mar-Apr

6.  Selective Serotonin Reuptake Inhibitors and Intracerebral Hemorrhage Risk and Outcome.

Authors:  Li Liu; Matthew Fuller; Tyler P Behymer; Yisi Ng; Thomas Christianson; Shreyansh Shah; Nicolas Kon Kam King; Daniel Woo; Michael L James
Journal:  Stroke       Date:  2020-03-04       Impact factor: 7.914

7.  Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study.

Authors:  Chung-Yao Chen; Chia-Ling Chen; Chung-Chieh Yu
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

Review 8.  Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke.

Authors:  F Chollet; J Rigal; P Marque; M Barbieux-Guillot; N Raposo; V Fabry; J F Albucher; J Pariente; I Loubinoux
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-23       Impact factor: 5.081

9.  Prevalence and Potential Associated Factors of Depression among Chinese Older Inpatients.

Authors:  T Xu; J Jiao; C Zhu; F Li; X Guo; J Li; M Zhu; Z Li; X Wu
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 10.  Use of antidepressant medications to improve outcomes after stroke.

Authors:  F Chollet; B Acket; N Raposo; J F Albucher; I Loubinoux; J Pariente
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.